Showing results (101-110 of 145) with videos related to
Sort By:
Pageof 15
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.Journal of Medical Internet Research|May 14, 2021
Use of Twitter in Neurology: Boon or Bane?Biswamohan Mishra, Monica Saini, Carolynne M Doherty, et al.Brain Research|December 15, 2021
Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axisUmadevi V Wesley, Ian Sutton, Paul A Clark, et al.Frontiers in Immunology|July 31, 2018
Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated SyndromeStephanie Trend, Anderson P Jones, Lilian Cha, et al.Wilderness & Environmental Medicine|April 9, 2005
Ataxia at altitude measured on a wobble boardBrian G Johnson, John Simmons, Alexander D Wright, et al.Clinical Immunology (Orlando, Fla.)|July 26, 2023
Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosisJennifer Massey, Crisbel Artuz, Zoe Dyer, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 22, 2018
A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS studyPrue H Hart, Anderson P Jones, Stephanie Trend, et al.Scientific Reports|May 30, 2019
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndromeStephanie Trend, Anderson P Jones, Lilian Cha, et al.Clinical Immunology (Orlando, Fla.)|January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapiesFiona C McKay, Prudence N Gatt, Nicole Fewings, et al.Frontiers in Immunology|February 7, 2022
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell TransplantationKevin Hendrawan, Melissa L M Khoo, Malini Visweswaran, et al.Pageof 15